Oscar Health, Inc. Stock Prediction and Forecast [OSCR]

AI-generated source summary

The analysis of Oscar Health (OSCR) stock indicates a mixed outlook. Since August 15, 2025, the system has rated the stock as a buy candidate with a score of 1.21. Those following the analysis would have seen gains of nearly 20% since the initial identification, averaging 0.94% daily. The stock is in a wide horizontal trend, expecting movements within it. The three-month trend indicates a potential change of 0.26% with possible returns ranging from -27.97% to 15.02%. The 12-month projection suggests a -7.28% change, varying between -45.86% and 4.40%. For the last trading day, the stock decreased by 3.10%, closing at $18.73, fluctuating 4.80% with a low of $18.32 and a high of $19.20, even with increase on Volume by 2 million shares. Analyst ratings are generally 'Strong Sell'. A stop-loss is recommended at $17.85(-4.70%). Short-term sell signal is presented and long-term is buy.

AI-generated summary based on the source content.

Evidence and evaluation progress

1. Original source published

   16 Sept 2025, 03:21 UTC

   The analyst published the original source item.

2. First prediction resolved

   16 Sept 2025, 13:30 UTC

   The first evaluable outcome in this case reached a terminal result.

3. Case evaluation completed

   16 Sept 2025, 13:30 UTC

   All evaluable predictions in this case reached terminal outcomes.

4. Source recorded by Tahlil Plus

   18 May 2026, 20:23 UTC

   The public source was preserved as the evidence record for this case.

5. Market predictions extracted

   18 May 2026, 20:47 UTC

   1 eligible signal linked to this case.

6. Outcome tracking started

   02 Jul 2026, 02:13 UTC

   Tahlil Plus began monitoring the extracted predictions.